Institutional Ownership Phoenix Biotech Acquisition CO (PBAXW)
This table provides information about the institutional ownership of Phoenix Biotech Acquisition CO (PBAXW). We have compiled data on the 34 institutions that hold shares in the stock, with a total of 5.53 Million shares, which have been reported (via 13F filing form) to have a value of $0.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Dupont Capital Management Corp
|
Jan 17, 2025 Q4 2024 |
12,500
shares
|
$0
0.0% of portfolio
|
Q4 2021
New holding
|
|
|
Calamos Advisors LLC
|
Jan 24, 2025 Q4 2024 |
12,500
shares
|
$0
0.0% of portfolio
|
Q3 2022
New holding
|
|
|
Silver Rock Financial LP
Los Angeles, CA |
Nov 14, 2024 Q3 2024 |
12,224
shares
|
$0
0.0% of portfolio
|
Q3 2023
Reduced 47.13%
|
|
|
Exos Tfp Holdings LLC
New York, NY |
Feb 14, 2024 Q4 2023 |
3,700
shares
|
$0
0.0% of portfolio
|
Q4 2022
New holding
|
|
|
Ancora Advisors, LLC
Cleveland, OH |
Nov 14, 2024 Q3 2024 |
2,500
shares
|
$0
0.0% of portfolio
|
Q1 2022
New holding
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2024 Q3 2024 |
800
shares
|
$0
0.0% of portfolio
|
Q3 2024
Added 14.29%
|
|
|
Tower Research Capital LLC (Trc)
New York, NY |
Nov 14, 2024 Q3 2024 |
87
shares
|
$0
0.0% of portfolio
|
Q1 2024
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Oct 10, 2024 Q3 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q3 2024
New holding
|